Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 5-year average of -1411.16%, near the high end of its 5-year range (-13767.88%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
-2049.09%
GROSS MARGIN AVG 5Y
-1411.16%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.44%
median of 748 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Praxis Precision Medicines, Inc.
Market Cap
$7.75B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2049.09%
5Y Avg
-1411.16%
Market Cap
$7.65B
Gross Margin
84.97%
TTM Avg
-824.36%
3Y Avg
-1521.85%
5Y Avg
-1048.03%
Market Cap
$7.61B
Gross Margin
84.52%
TTM Avg
78.41%
3Y Avg
74.39%
5Y Avg
74.39%
Market Cap
$7.93B
Gross Margin
69.66%
TTM Avg
54.89%
3Y Avg
42.48%
5Y Avg
46.51%
Market Cap
$7.33B
Gross Margin
98.16%
TTM Avg
98.36%
3Y Avg
98.29%
5Y Avg
98.36%
Market Cap
$8.39B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
Market Cap
$8.58B
Gross Margin
101.98%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.75B | 0.00% | 0.00% | -2049.09% | -1411.16% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.65B | 84.97% | -824.36% | -1521.85% | -1048.03% |
| HealthEquity, Inc. (HQY)vs › | $7.66B | 75.21% | 63.63% | 56.54% | 52.91% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 84.52% | 78.41% | 74.39% | 74.39% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | 69.66% | 54.89% | 42.48% | 46.51% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.33B | 98.16% | 98.36% | 98.29% | 98.36% |
| Oscar Health, Inc. (OSCR)vs › | $8.39B | 14.38% | 17.24% | 38.82% | 59.22% |
| Alkermes plc (ALKS)vs › | $7.02B | 84.56% | 85.47% | 84.03% | 83.69% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.58B | 101.98% | 100.00% | 100.00% | 100.00% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.77B | 100.00% | -161.83% | -33.28% | -5.52% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -654.23% |
| 2024-09-30 | -13767.88% |
| 2024-06-30 | -7535.85% |
| 2024-03-31 | -6160.79% |
| 2023-12-31 | -3470.49% |
| 2023-09-30 | -3588.03% |
| 2023-06-30 | -3179.64% |
| 2023-03-31 | -3634.11% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
